|
|
||||||||
-Lactalbumin unfolding is not sufficient to cause apoptosis, but is required for the conversion to HAMLET (human
-lactalbumin made lethal to tumor cells)
1 Department of Microbiology, Immunology and Glycobiology (MIG), Institute of Laboratory Medicine, and
2 Department of Biophysical Chemistry, Lund University, Lund, Sweden
3 Departments of Veterinary Biosciences and Chemistry, The Ohio State University, Columbus, Ohio 43210, USA
4 Department of Chemistry and Biochemistry, University of Denver, Denver, Colorado 80208-2436, USA
Reprint requests to: Catharina Svanborg, Department of Microbiology, Immunology and Glycobiology (MIG), Institute of Laboratory Medicine, Lund University, Sölvegatan 23, S-223 62 Lund, Sweden; e-mail: Catharina.Svanborg{at}mig.lu.se; fax: 46-46-137468.
HAMLET (human
-lactalbumin made lethal to tumor cells) is a complex of human
-lactalbumin and oleic acid (C18:1:9 cis) that kills tumor cells by an apoptosis-like mechanism. Previous studies have shown that a conformational change is required to form HAMLET from
-lactalbumin, and that a partially unfolded conformation is maintained in the HAMLET complex. This study examined if unfolding of
-lactalbumin is sufficient to induce cell death. We used the bovine
-lactalbumin Ca2+ site mutant D87A, which is unable to bind Ca2+, and thus remains partially unfolded regardless of solvent conditions. The D87A mutant protein was found to be inactive in the apoptosis assay, but could readily be converted to a HAMLET-like complex in the presence of oleic acid. BAMLET (bovine
-lactalbumin made lethal to tumor cells) and D87A-BAMLET complexes were both able to kill tumor cells. This activity was independent of the Ca2+site, as HAMLET maintained a high affinity for Ca2+ but D87A-BAMLET was active with no Ca2+ bound. We conclude that partial unfolding of
-lactalbumin is necessary but not sufficient to trigger cell death, and that the activity of HAMLET is defined both by the protein and the lipid cofactor. Furthermore, a functional Ca2+-binding site is not required for conversion of
-lactalbumin to the active complex or to cause cell death. This suggests that the lipid cofactor stabilizes the altered fold without interfering with the Ca2+site.
Keywords:
-Lactalbumin; Ca2+-binding site; protein folding; HAMLET; tumor cell death
Abbreviations: CD, circular dichroism ANS, 8-Anilinonaphtalene-1-sulfonic acid Tris, tris(hydroxymethyl)aminomethane EDTA, ethylenediamine tetra acetic acid FPLC, fast protein liquid chromatography PBS, phosphate-buffered saline UV, ultraviolet DEAE, diethylaminoethyl quin 2, 2[[2[bis(carboxymethyl)amino-5-methylphenoxy]methyl]-6-methoxy-8[bis(carboxymethyl)amino]quinoline
![]()
CiteULike
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
L. Gustafsson, O. Hallgren, A.-K. Mossberg, J. Pettersson, W. Fischer, A. Aronsson, and C. Svanborg HAMLET Kills Tumor Cells by Apoptosis: Structure, Cellular Mechanisms, and Therapy J. Nutr., May 1, 2005; 135(5): 1299 - 1303. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Fast, A.-K. Mossberg, C. Svanborg, and S. Linse Stability of HAMLET--A kinetically trapped {alpha}-lactalbumin oleic acid complex Protein Sci., February 1, 2005; 14(2): 329 - 340. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |